These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17451426)

  • 21. Preservation of beta-cell function by targeting beta-cell mass.
    de Koning EJ; Bonner-Weir S; Rabelink TJ
    Trends Pharmacol Sci; 2008 Apr; 29(4):218-27. PubMed ID: 18359095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-cells in type 2 diabetes: a loss of function and mass.
    Maedler K; Donath MY
    Horm Res; 2004; 62 Suppl 3():67-73. PubMed ID: 15539803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A biomarker concept for assessment of insulin resistance, beta-cell function and chronic systemic inflammation in type 2 diabetes mellitus.
    Pfützner A; Weber MM; Forst T
    Clin Lab; 2008; 54(11-12):485-90. PubMed ID: 19216254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Islet cell function: alpha and beta cells--partners towards normoglycaemia.
    Göke B
    Int J Clin Pract Suppl; 2008 Mar; (159):2-7. PubMed ID: 18269435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm.
    Portha B
    Diabetes Metab Res Rev; 2005; 21(6):495-504. PubMed ID: 15926190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoring a functional beta-cell mass in diabetes.
    Pipeleers D; Chintinne M; Denys B; Martens G; Keymeulen B; Gorus F
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():54-62. PubMed ID: 18834433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.
    Wilson PW; Meigs JB; Sullivan L; Fox CS; Nathan DM; D'Agostino RB
    Arch Intern Med; 2007 May; 167(10):1068-74. PubMed ID: 17533210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance and pancreatic beta cell failure.
    Kasuga M
    J Clin Invest; 2006 Jul; 116(7):1756-60. PubMed ID: 16823472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging role of FOXO transcription factors in pancreatic beta cells.
    Glauser DA; Schlegel W
    J Endocrinol; 2007 May; 193(2):195-207. PubMed ID: 17470511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood obesity and type 2 diabetes mellitus.
    Hannon TS; Rao G; Arslanian SA
    Pediatrics; 2005 Aug; 116(2):473-80. PubMed ID: 16061606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Executioners of apoptosis in pancreatic {beta}-cells: not just for cell death.
    Choi D; Woo M
    Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E735-41. PubMed ID: 20028968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced insulin signaling and endoplasmic reticulum stress act synergistically to deteriorate pancreatic beta cell function.
    Matsuda T; Kido Y; Uchida T; Kasuga M
    Kobe J Med Sci; 2008 Jul; 54(2):E114-21. PubMed ID: 18772613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
    Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes.
    Cnop M
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):348-52. PubMed ID: 18481955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
    Adewole SO; Ojewole JA
    Methods Find Exp Clin Pharmacol; 2007 Sep; 29(7):447-55. PubMed ID: 17982509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 2 diabetes - a matter of failing beta-cell neogenesis? Clues from the GK rat model.
    Movassat J; Calderari S; Fernández E; Martín MA; Escrivá F; Plachot C; Gangnerau MN; Serradas P; Alvarez C; Portha B
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():187-95. PubMed ID: 17919193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery from diabetes in mice by beta cell regeneration.
    Nir T; Melton DA; Dor Y
    J Clin Invest; 2007 Sep; 117(9):2553-61. PubMed ID: 17786244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of pancreatic beta-cell function by adipocytes.
    Zhao YF; Chen C
    Sheng Li Xue Bao; 2007 Jun; 59(3):247-52. PubMed ID: 17579776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
    Patriti A; Aisa MC; Annetti C; Sidoni A; Galli F; Ferri I; Gullà N; Donini A
    Surgery; 2007 Jul; 142(1):74-85. PubMed ID: 17630003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.